Logo

Tissue Bank Company Asterand Closes Series C

Nov 21, 2003

NEW YORK, Nov. 21 (GenomeWeb News) - Asterand, which runs a human tissue research bank that supplies genomics and proteomics researchers, said today it has closed a Series C round of funding, but did not disclose the amount of funds raised.

 

The company, based in Detroit, raised the funds from Apjohn Ventures in Ann Arbor, Mich., and Chrysalis Ventures of Louisville, KY, as well as existing investors Oxford Bioscience and Fort Washington Capital Partners.

 

Asterand was founded in 2000 by Randal Charlton, its current CEO, and Alan Walton, general partner at Oxford Bioscience partners. It collects material that covers over 150 diseases, including diabetes, cancer, cardiovascular disease, rheumatoid arthritis and Alzheimer's, schizophrenia, and biopolar disorder.

Breaking News
The Scan

Genome Sequences Reveal Range Mutations in Induced Pluripotent Stem Cells

Researchers in Nature Genetics detect somatic mutation variation across iPSCs generated from blood or skin fibroblast cell sources, along with selection for BCOR gene mutations.

Researchers Reprogram Plant Roots With Synthetic Genetic Circuit Strategy

Root gene expression was altered with the help of genetic circuits built around a series of synthetic transcriptional regulators in the Nicotiana benthamiana plant in a Science paper.

Infectious Disease Tracking Study Compares Genome Sequencing Approaches

Researchers in BMC Genomics see advantages for capture-based Illumina sequencing and amplicon-based sequencing on the Nanopore instrument, depending on the situation or samples available.

LINE-1 Linked to Premature Aging Conditions

Researchers report in Science Translational Medicine that the accumulation of LINE-1 RNA contributes to premature aging conditions and that symptoms can be improved by targeting them.